Chlamydia Diagnostics Market Analysis and Opportunity Assessment 2023 to 2033

The global Chlamydia Diagnostics market revenue is expected to reach US$ 3.69 billion by 2033. The market's expansion could be attributed to growing awareness of the importance of STI testing.

The Chlamydia Diagnostics market in Europe is expected to grow rapidly in the next years due to a variety of causes. The increased prevalence of chlamydia in the region is one of the key market reasons. According to a study conducted by the European Centre for Disease Prevention and Control, the number of reported chlamydia infections in Europe has steadily climbed over the last decade, with over 410,000 cases reported in 2019. The demand for Chlamydia Diagnostics in the region is expected to rise as the prevalence of chlamydia rises.

The availability of enhanced diagnostic tests is another major reason driving the growth of the Chlamydia Diagnostics market. Because of their high sensitivity and specificity, nucleic acid amplification tests (NAATs) are the most often utilised chlamydia diagnostic tests.

Furthermore, because these tests can detect bacterial DNA in a patient's urine, swab, or blood sample, they provide patients with a handy and non-invasive option. Rapid diagnostic technologies, such as the Alere i platform and the Roche Cobas Liat System, have also been developed in recent years, enabling for rapid and accurate chlamydia detection.

Key Takeaways from the Market Study

  • NAATs are expected to account for 49% of the Chlamydia Diagnostics market in 2023.
  • The global Chlamydia Diagnostics market is expected to grow at an 11% CAGR between 2023 and 2033.
  • North America is expected to represent 48% of the Chlamydia Diagnostics market in 2023.
  • The European Chlamydia Diagnostics market is expected to account for 46% of the total by 2023.

Competitive Landscape

Key players in the Chlamydia Diagnostics market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Hologic, Inc., Quidel Corporation, DiaSorin SpA Becton, Dickinson and Company, Bio-Rad Laboratories, Pfizer, Inc., AstraZeneca and Teva Pharmaceuticals

Read More@ https://www.futuremarketinsights.com/reports/chlamydia-diagnostics-market

Key Segments Profiled in the Chlamydia Diagnostics Industry Survey

Test Type:

  • Culture Tests
  • Nucleic Acid Amplification Tests (NAAT)
  • Direct Fluorescent Antibody Tests
  • Serology Tests

End User:

  • Hospitals
  • Clinics
  • Diagnostic Centres

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasoun...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies

Image
A recently published study by FMI expects the global  Aesthetic Medical Devices Market  to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals. In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages. Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd. Key Takeaways from the Market Study FMI projects the global aesthetic ...
Read more